Medicare Enrolled

Dr. Patrick Shenot, M.D.

Urology Physician · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
833 CHESTNUT ST, Philadelphia, PA 19107
2159551000
In practice since 2006 (19 years)
NPI: 1740209493 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shenot from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shenot? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shenot

Dr. Patrick Shenot is an urology physician in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shenot performed 901 Medicare services across 824 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shenot received a total of $11,380 from 23 pharmaceutical and/or device companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shenot is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 901 Medicare services $11,380 industry payments

Medicare Practice Summary

Medicare Utilization ↗
901
Medicare services
Bottom 48% in PA for urology physician
824
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~47 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
94 $83 $280
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
94 $32 $130
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
91 $15 $210
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
84 $53 $185
Radiologist review of bladder and urethra images with contrast
A radiologist reviews medical images of the urinary bladder and urethra taken with contrast dye, including images captured after the patient has urinated.
75 $13 $50
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
68 $61 $700
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
57 $60 $275
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
55 $3 $160
Cystoscopy with chemical ablation of bladder
A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue.
53 $115 $1,500
Simple change of bladder tube 40 $37 $210
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
30 $112 $350
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
26 $59 $175
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $73 $275
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
22 $20 $180
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
21 $126 $880
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
19 $37 $360
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
17 $394 $2,435
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
17 $109 $245
Injection of implant material into bladder or urethra
A procedure where implant material is injected beneath the lining of the bladder and/or urethra using an endoscope.
13 $148 $1,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
3.9% medium
86.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$11,380
Total received (2018-2024)
Avg $1,626/year across 7 years
Top 13% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
117
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,970 (61.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,410 (38.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,007
2023
$2,097
2022
$1,832
2021
$1,359
2020
$1,164
2019
$1,645
2018
$1,277

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$1,125
Medtronic, Inc.
$314
COLOPLAST CORP
$141
BLUEWIND MEDICAL
$62
UROGEN PHARMA, INC.
$60
Smith+Nephew, Inc.
$59
Sumitomo Pharma America, Inc.
$48
180 Medical, Inc.
$31
Teleflex LLC
$30
Corcept Therapeutics
$29
Astellas Pharma US Inc
$29
PROGENICS PHARMACEUTICALS, INC.
$29
ABBVIE INC.
$19
Janssen Biotech, Inc.
$17
Boston Scientific Corporation
$16
Top 3 companies account for 78.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$4,720
Merck Sharp & Dohme LLC
$2,250
Medtronic, Inc.
$1,412
Coloplast Corp
$1,345
Medtronic USA, Inc.
$422
180 Medical, Inc.
$252
COLOPLAST CORP
$154
Myriad Genetic Laboratories, Inc.
$137
Boston Scientific Corporation
$93
Sumitomo Pharma America, Inc.
$71
BLUEWIND MEDICAL
$62
UROGEN PHARMA, INC.
$60
Smith+Nephew, Inc.
$59
Teleflex LLC
$59
Astellas Pharma US Inc
$58
ABBVIE INC.
$42
ABC Home Medical Supply, Inc.
$37
Calyxo, Inc.
$35
Corcept Therapeutics
$29
PROGENICS PHARMACEUTICALS, INC.
$29
Hollister Incorporated
$20
AbbVie Inc.
$19
Janssen Biotech, Inc.
$17
Top 3 companies account for 73.7% of all-time payments
Associated products mentioned in payments ›
BOTOX · CVAC · Coloplast TFL Drive · ERLEADA · GEMTESA · GENERAL - ERECTILE DYSFUNCTION · GENTLECATH · General - Erectile Dysfunction · GentleCath · INTERSTIM · JELMYTO · Korlym · PROLARIS · PYLARIFY · REVI · STRAVIX · STRAVIX PL · SWISS LITHOCLAST TRILOGY · SpeediCath · UROLIFT · VaPro Pocket · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (61%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for an urology physician in Philadelphia?
Compare urology physicians in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
297
Per 100K population
18.8
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shenot is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 13% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shenot experienced with complex urodynamic pressure flow study?
Based on Medicare claims data, Dr. Shenot performed 94 complex urodynamic pressure flow study services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shenot receive payments from pharmaceutical companies?
Yes. Dr. Shenot received a total of $11,380 from 23 companies across 117 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shenot's costs compare to other urology physicians in Philadelphia?
Dr. Shenot's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shenot) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →